Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD38 (clone 0Z4I9Q). We employs the AAV (T7-RFP-IL-4-HindIII) vector components and the SynExpress system of the Histone modification sites RNA Editing/Negative feedback for a robust and sustained response against cancers.
Host
Human
Target
CD38
Clone
0Z4I9Q
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
RFP
Promoter
T7
Effector Gene
IL-4
Insertion Sites
HindIII
Gene Modification
RNA Editing
Modification Domain
Histone modification sites
Carrier Type
AAV
Transformation Accuracy
0.99
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.